Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
Ticker Information
Ticker
SAGECompany Name
SAGE THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQSAGE THERAPEUTICS INC - Enterprise Value over Free Cash Flow Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
SAGE - EV/FCF Historical data
| Date | Enterprise Value | Enterprise Value over Free Cash Flow | Free Cash Flow |
|---|---|---|---|
| 6/30/2025 | $ 487.45M | 0 | $ -289.34M |
| 3/31/2025 | $ 441.1M | 0 | $ -311.09M |
| 12/31/2024 | $ 371.41M | 0 | $ -267.19M |
| 9/30/2024 | $ 428.06M | 0 | $ -320.04M |
| 6/30/2024 | $ 568.68M | 0 | $ -373.87M |
| 3/31/2024 | $ 645.09M | 0 | $ -425.06M |
| 12/31/2023 | $ 1.48B | 0 | $ -541.14M |
| 9/30/2023 | $ 1.03B | 0 | $ -548.95M |
| 6/30/2023 | $ 889.04M | 0 | $ -531.98M |
| 3/31/2023 | $ 2.52B | 0 | $ -506.91M |
Key Performance Insights, Last 5 Years
- SAGE THERAPEUTICS INC's latest trailing twelve months (TTM) EV/FCF stands at 0.
- Over the past 5 years, SAGE THERAPEUTICS INC's average EV/FCF has been 3.87.
- The median EV/FCF for SAGE THERAPEUTICS INC during this period was 3.85
- SAGE THERAPEUTICS INC reached its highest EV/FCF over the past 5 years at 5.02.
- The lowest EV/FCF recorded by SAGE THERAPEUTICS INC in the same timeframe 2.77
SAGE THERAPEUTICS INC's EV/FCF vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
EV/FCF Benchmarks
Similar metrics to FCF:
- Price to Free Cash Flow - [Calculation] Measures a company’s [MarketCap] in relation to its Free Cash Flow [FCF].
- Enterprise Value over EBIT - [Calculation] Measures a company’s Enterprise Value [EV] in relation to its earnings before interest and taxes [EBIT].
- Enterprise Value over EBITDA - [Calculation] Measures a company’s Enterprise Value [EV] in relation to its earnings before interest, taxes, depreciation, and amortization [EBITDA].
- Price to Operating Cash Flow - [Calculation] Measures a company’s [MarketCap] in relation to its Operating Cash Flow [NCFO].
- Price to Sales - [Calculation] Measures a company’s [MarketCap] in relation to its [Revenue].
Definition of Enterprise Value over Free Cash Flow
[Calculation] Measures a company’s Enterprise Value [EV] in relation to its Free Cash Flow [FCF].EV / FCF
(=) EV/FCF EV/FCF for SAGE THERAPEUTICS INC is calculated as follows: EV [ $ 3.91B ] / FCF [ $ -464.13M ]
(=) EV/FCF [ 0 ] SAGE - Enterprise Value over Free Cash Flow, Last 5 years
2.77
Minimum
Jun 30, 2021
5.02
Maximum
Dec 31, 2020
3.87
Average
3.85
Median
EV/FCF Benchmark AnalysisMarket
The chart above depicts the distribution of EV/FCF for companies in the Total Stock Market. The average EV/FCF of the companies is 23.44 with a standard deviation of 16.12.
The following table provides additional summary stats:
EV/FCF in the Market:
| filtered constituents | 2.2K |
|---|---|
| min | 0.05 |
| max | 77.98 |
| average | 23.44 |
| median | 19.08 |
| std | 16.12 |